MetLife Investment Management’s NRC Health Common Stock NRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $144K | Hold |
6,673
| – | – | ﹤0.01% | 2599 |
|
|
2026
Q1 | $113K | Sell |
6,673
-307
| -4% | -$5.22K | ﹤0.01% | 2485 |
|
|
2025
Q4 | $131K | Sell |
6,980
-4,650
| -40% | -$70.2K | ﹤0.01% | 2478 |
|
|
2025
Q3 | $149K | Hold |
11,630
| – | – | ﹤0.01% | 2477 |
|
|
2025
Q2 | $195K | Hold |
11,630
| – | – | ﹤0.01% | 2213 |
|
|
2025
Q1 | $149K | Hold |
11,630
| – | – | ﹤0.01% | 2350 |
|
|
2024
Q4 | $205K | Buy |
11,630
+2,592
| +29% | +$49.2K | ﹤0.01% | 2291 |
|
|
2024
Q3 | $207K | Hold |
9,038
| – | – | ﹤0.01% | 2273 |
|
|
2024
Q2 | $207K | Buy |
9,038
+1,799
| +25% | +$55.5K | ﹤0.01% | 2221 |
|
|
2024
Q1 | $287K | Hold |
7,239
| – | – | ﹤0.01% | 1979 |
|
|
2023
Q4 | $286K | Hold |
7,239
| – | – | ﹤0.01% | 2032 |
|
|
2023
Q3 | $321K | Hold |
7,239
| – | – | ﹤0.01% | 1898 |
|
|
2023
Q2 | $315K | Hold |
7,239
| – | – | ﹤0.01% | 1980 |
|
|
2023
Q1 | $315K | Hold |
7,239
| – | – | ﹤0.01% | 1925 |
|
|
2022
Q4 | $270K | Buy |
7,239
+292
| +4% | +$11.3K | ﹤0.01% | 2057 |
|
|
2022
Q3 | $276K | Sell |
6,947
-903
| -12% | -$33.4K | ﹤0.01% | 2081 |
|
|
2022
Q2 | $300K | Sell |
7,850
-1,606
| -17% | -$58.1K | ﹤0.01% | 2022 |
|
|
2022
Q1 | $375K | Buy |
9,456
+3,250
| +52% | +$127K | ﹤0.01% | 1959 |
|
|
2021
Q4 | $258K | Hold |
6,206
| – | – | ﹤0.01% | 1899 |
|
|
2021
Q3 | $262K | Hold |
6,206
| – | – | ﹤0.01% | 1911 |
|
|
2021
Q2 | $285K | Hold |
6,206
| – | – | ﹤0.01% | 1927 |
|
|
2021
Q1 | $291K | Hold |
6,206
| – | – | ﹤0.01% | 1830 |
|
|
2020
Q4 | $265K | Hold |
6,206
| – | – | ﹤0.01% | 1828 |
|
|
2020
Q3 | $305K | Hold |
6,206
| – | – | ﹤0.01% | 1622 |
|
|
2020
Q2 | $361K | Buy |
6,206
+1,237
| +25% | +$65.3K | ﹤0.01% | 1553 |
|
|
2020
Q1 | $226K | Hold |
4,969
| – | – | ﹤0.01% | 1631 |
|
|
2019
Q4 | $328K | Hold |
4,969
| – | – | ﹤0.01% | 1690 |
|
|
2019
Q3 | $287K | Sell |
4,969
-1,712
| -26% | -$106K | ﹤0.01% | 1732 |
|
|
2019
Q2 | $385K | Sell |
6,681
-8,169
| -55% | -$378K | ﹤0.01% | 1633 |
|
|
2019
Q1 | $573K | Buy |
14,850
+9,900
| +200% | +$388K | ﹤0.01% | 1978 |
|
|
2018
Q4 | $189K | Hold |
4,950
| – | – | ﹤0.01% | 1939 |
|
|
2018
Q3 | $191K | Hold |
4,950
| – | – | ﹤0.01% | 2109 |
|
|
2018
Q2 | $185K | Hold |
4,950
| – | – | ﹤0.01% | 1953 |
|
|
2018
Q1 | $145K | Hold |
4,950
| – | – | ﹤0.01% | 2052 |
|
|
2017
Q4 | $185K | Buy |
+4,950
| New | +$176K | ﹤0.01% | 1975 |
|
Other funds holding NRC
WIC
QI
MetLife Investment Management's NRC Position: Q2 2026 in Review
MetLife Investment Management held its NRC Health Common Stock (NRC) position steady in Q2 2026 at 6,673 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #2599.
MetLife Investment Management first reported a position in NRC in Q4 2017 and has held it in 35 quarters since. The position peaked at $573K in Q1 2019. 123 funds tracked by Wall St. Rank hold NRC as of Q2 2026.
- MetLife Investment Management held 6,673 shares of NRC Health Common Stock worth $144K as of Q2 2026.
- MetLife Investment Management left its NRC Health Common Stock share count unchanged in Q2 2026.
- NRC Health Common Stock made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2599 holding.
- MetLife Investment Management first reported a position in NRC Health Common Stock in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's NRC Health Common Stock position peaked at $573K in Q1 2019.
- 123 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.